Use of recombinant activated factor VII for reduction of perioperative blood loss during elective surgical correction of spine deformity in a Jehovah’s Witness. Case repor Katarzyna Kącka , Wojciech Kącki , Joanna Merak , Adam Błęka Ortop Traumatol Rehabil 2010; 12(5):448-458 ICID: 922681
Article type: Case report
IC™ Value: 4.54
Abstract provided by Publisher
Planned surgical procedures at patients who refuse allogenic blood transfusion because of religious convictions are important problem, not only medical but also ethical and juristical. At the study authors report the successful use of activated recombinant factor VII (rFVIIa) for the reduction of perioperative blood loss in four years old child - Jehovah’s Witness, who had planned Torode kyphectomy. Applied perioperative management together with preparing to surgery with erythropoietin allowed for reduction of blood loss and avoiding of blood transfusion. Authors state, that appropriate perioperative proceeding makes a possibility of safe surgical procedures also at patients who refuse the transfusion.
ICID 922681 PMID 21057153 - click here to show this article in PubMed